SCHEMBL5587534

SCHEMBL5587534

COc1cc(C(C)(C)C)c(O)c(O)c1C(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.55
TP53 P04637 2/20 0.55
LMNA P02545 1/20 0.55
CYP3A4 P08684 1/20 0.55
HPGD P15428 1/20 0.55
CA2 P00918 3/20 0.53
CA1 P00915 2/20 0.53
SMN1; SMN2 Q16637 4/20 0.43
ALDH1A1 P00352 3/20 0.43
POLB P06746 1/20 0.43
TYR P14679 1/20 0.43
PTGS2 P35354 3/20 0.40
PTGS1 P23219 2/20 0.40
HTR2A P28223 1/20 0.40
CYP1A2 P05177 2/20 0.39
MAPT P10636 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
HPN P05981 1/20 0.39
SIRT5 Q9NXA8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8445665 0.88 ALOX15 (0.55) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL785005 0.85 TP53 (0.52) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL1144365 0.81 CYP3A4 (0.52) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL5587537 0.80 LMNA (0.44) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL5590038 0.79 PTGS1 (0.44) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL11777253 0.79 GLRA3 (0.61) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL14788891 0.78 TP53 (0.47) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL5590048 0.77 PTGS1 (0.47) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL31487092 0.76 TP53 (0.46) ALOX15TP53LMNACYP3A4HPGD
SCHEMBL61454 0.76 TP53 (0.46) ALOX15TP53LMNACYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US claimed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP claimed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US claimed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP claimed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO claimed
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALOX15 76/4885TP53 3753/4885LMNA 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.